Clinical Trials Logo

Dermatitis, Radiation-Induced clinical trials

View clinical trials related to Dermatitis, Radiation-Induced.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04483856 Completed - Radiodermatitis Clinical Trials

Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.

DRESDA
Start date: November 2, 2020
Phase: N/A
Study type: Interventional

This is a post marketing, interventional, randomized, single-center, prospective, controlled study, for the evaluation of the clinical performance and tolerability of a cream-based medical device (DermoRelizemaTM cream) in the management care of radiodermatitis in women with breast cancer. Assessments and evaluations will be performed by a physician in a blind fashion. The primary objective is Evaluation of the effects of DermoRelizemaTM cream in the management of the progression of RT-induced skin reactions and toxicity, using the grading system of the Radiation Therapy Oncology Group / European Organization for Research and Treatment of Cancer (RTOG/ EORTC), at the conclusion of the treatment period